Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1996-6-27
pubmed:abstractText
Graft-versus-host disease (GVHD) is the main complication after allogeneic bone marrow transplantation. Although the tissue damage and subsequent patient mortality are clearly dependent on T lymphocytes present in the grafted inoculum, the lethal effector molecules are unknown. Here, we show that acute lethal GVHD, induced by the transfer of splenocytes from C57BL/6 mice into sensitive BALB/c recipients, is dependent on both perforin and Fas ligand (FasL)-mediated lytic pathways. When spleen cells from mutant mice lacking both effector molecules were transferred to sublethally irradiated allogeneic recipients, mice survived. Delayed mortality was observed with grafted cells deficient in only one lytic mediator. In contrast, protection from lethal acute GVHD in resistant mice was exclusively perforin dependent. Perforin-FasL-deficient T cells failed to lyse most target cells in vitro. However, they still efficiently killed tumor necrosis factor alpha-sensitive fibroblasts, demonstrating that cytotoxic T cells possess a third lytic pathway.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-1372394, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-1649771, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-1994250, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-2108082, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-2783478, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-2880163, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-2891262, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-3306918, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-3316469, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-3891901, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-3910556, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-56872, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-6693832, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-7511063, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-7513193, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-7518614, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-7520535, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-7526382, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-7528774, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-7530197, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-7533086, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-7533326, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-7533644, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-7536631, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-7689176, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-7737114, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-7774281, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-7889405, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-7919322, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-7972104, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-8102263, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-8137431, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-8164737, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-8240742, http://linkedlifedata.com/resource/pubmed/commentcorrection/8627178-8506280
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0022-1007
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
183
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
657-61
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease.
pubmed:affiliation
Ludwig Institute for Cancer Research, University of Lausanne, Epalinges, Switzerland.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't